BIONNOVATION
LIVE

Serial Number

99424692

Owner

Geistlich Pharma AG

Attorney

LEO M. LOUGHLIN

Filing Date

Oct 2, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BIONNOVATION Trademark

Serial Number: 99424692

BIONNOVATION is a trademark filed by Geistlich Pharma AG on October 2, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment). The application is currently pending registration.

Owner Contact Info

Geistlich Pharma AG (2 trademarks)

Bahnhofstrasse 40
Wolhusen CH-6110 , CH

Entity Type: 99

Trademark Details

Filing Date

October 2, 2025

Registration Date

Not Registered

Goods & Services

Taurolidine containing pharmaceutical and veterinary preparations and substances for prevention or treatment of periodontitis or peritonitis; sanitary preparations for medical purposes; hemostatics for medical purposes; wound dressing material; wound sponges impregnated with antiseptics; medical adhesives for binding internal tissue; medical plasters; pharmaceutical preparations for the treatment of wounds and ulcers, and diabetic ulcers, and for the treatment of orthopedic conditions, namely, cartilage defects, meniscus injuries, and ligament injuries; material for filling teeth and materials for dental impressions; ceramics and cement for teeth and bones for orthopedic and surgical use; disinfectants; biological membrane and noncollagen tissues intended for subsequent implantation; surgical collagen implants; surgical collagen adhesive dressings; natural biomaterials for augmentation of bone and tissue for medical purposes; natural bone implant materials, namely, biological bone tissue

Organization of seminars, workshops, training and continuing education courses in the fields of application of taurolidine, sanitary preparations, wound dressing material, wound sponges, medical adhesives, filling and implant materials, medical plasters, biocompatible collagen-material, in particular biocompatible collagen-membranes, biocompatible collagen-matrixes or biocompatible collagen-sponge, surgical collagen-implants, surgical collagen-adhesives, resorbable implants for use in dental, maxillofacial, orthopedic or visceral surgery

Surgical, medical, dental and veterinary apparatus and instruments in the nature of resorbable implants composed of artificial materials; orthopedic articles in the nature of resorbable implants composed of artificial materials; fillers and implants composed of artificial materials for use in dental, maxillofacial and orthopedic surgery for the regeneration of bone and soft tissue filling and implant materials derived from natural substances for dental, maxillofacial and orthopedic surgery, especially for the regeneration of bone and soft tissue; biocompatible collagen-material, namely, biocompatible collagen barrier membranes, biocompatible collagen-matrixes, and biocompatible collagen-sponges for use in dental, maxillofacial and orthopedic surgery, for the regeneration of bone and soft tissue, or for use as a hemostatic agent in the surgery and dressing; artificial teeth; artificial jaws; dentures; sets of artificial teeth; prostheses for dental purposes and orthopedic purposes, namely, dental prostheses and joint prostheses; teething rings; surgical implants composed of artificial materials; dental drills; dental appliances, namely, ultrasound appliances for dental use; electrical dental instruments, namely, dental drills, dental handpieces, and ultrasonic dental scalers; surgical drills; milling apparatus for dental purposes; surgical instruments, namely, contra-angles, surgical engines, implant stability gauges; custom dentures; synthetic bone grafts; artificial biomaterials for augmentation of bone and tissue for medical purposes; dental equipment, namely, personal protective equipment in the nature of face shields; prosthetic components, namely, cushion liners for prosthetic limbs; surgical instruments

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 13, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 13, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 13, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 2, 2025 MAFR
NEW APPLICATION ENTERED
Oct 2, 2025 NWAP